Table 2 Outcomes of hospitalized patients with COVID-19 pneumonia
Outcomes | Overall (n = 1539) | Short corticosteroids (n = 412) | Prolonged corticosteroids (n = 1127) | p |
|---|---|---|---|---|
All hospitalized patients (n = 1539) | ||||
In-hospital mortality (n, %) | 552 (35.9) | 107 (26) | 445 (39.5) | < 0.001 |
ICU mortality (n, %) | 473 (30.7) | 75 (18.2) | 398 (35.3) | < 0.001 |
Hospital LOS (days) | 23 (16–33) | 17 (13–24) | 25 (17–36) | < 0.001 |
Transfer to another facility (n, %) | 138 (9) | 35 (8.5) | 103 (9.1) | 0.771 |
ICU LOS (days) | 16 (8–27) | 11 (5–17) | 19 (10–30) | < 0.001 |
Time spent on MV (days) | 16 (10–27) | 11 (6–15) | 18 (11–29) | < 0.001 |
Number of antibiotics used | 4 (2–6) | 2 (1–4) | 4 (2–6) | < 0.001 |
Days on antibiotics | 16 (8–31) | 11 (6–20) | 20 (10–34) | < 0.001 |
Number of positive hemoculture | 0.00 [0.00, 2.00] | 0.00 [0.00, 1.00] | 1.00 [0.00, 2.00] | < 0.001 |
Overall (n = 622) | Short corticosteroids (n = 163) | Prolonged corticosteroids (n = 459) | p | |
|---|---|---|---|---|
Critically ill patients (n = 622) | ||||
In-hospital mortality (n, %) | 267 (42.9) | 44 (27) | 223 (48.6) | < 0.001 |
ICU mortality (n, %) | 258 (41.5) | 41 (25.2) | 217 (47.3) | < 0.001 |
Hospital LOS (days) | 25 (17–35) | 18 (14–28) | 27 (19–38) | < 0.001 |
ICU LOS (days) | 21 (14–31) | 14 (11–21) | 23 (16–34) | < 0.001 |
Time spent on MV (days) | 18 (12–29) | 13 (7–19) | 21 (14–32) | < 0.001 |
Number of antibiotics used | 5 (3–7) | 4 (2–5) | 5 (4–7) | < 0.001 |
Days on antibiotics | 23 (12–38) | 13 (7–24) | 26 (14–42) | < 0.001 |
Number of positive hemoculture | 1.00 [0.00, 2.00] | 1.00 [0.00, 2.00] | 1.00 [0.00, 2.00] | < 0.001 |